ACKEMANN, J., et al, Celsior Vs. Custodiol® – Early Postischemic Recovery after Cardioplegia at 5ºC., Annals of Thoracic Surgery, 2002;74:522-529

ARSLAN, A., et al, Low-Dose Histidine-Tryptophan-Ketoglutarate for Myocardial Protection, Transplantation Proceedings, 37, 3219-3222 (2005)

BRETSCHNEIDER, H.J., et al, Cardioplegia – Principles and Problems. Physiol. And Pathophysiololgy of the Human Heart., M. Nijhoff Public. Boston, 1984, p. 605-616

BRETSCHNEIDER, H.J., et al, Myocardial Protection, Thorac. Cardiovasc. Surg., 28 (1980), 295-302

BRETSCHNIDER, H.J., et al, Significance of Myocardial Predamage and Condition in Ischemic Tolerance of the Heart, in: Cardiothoracic Surgery, K. Minami et al (ed), Elsevier Science Publishers, 1992, p. 35-44

CAREAGA, G., et al, Clinical Impact of Histidine-Tryptophan-Ketoglutarate (HTK) Cardioplegic Solution on the Perioperative Period in Open Heart Surgery Patients, Arch. Of Medical Research 32, (2001) 296-299

GALLANDAT, R.C.G., et al, Clinical Effect of Bretschneider HTK and St. Thomas Cardioplegia on Hemodynamic Performance after Bypass Measured, Thorac. Cardiovasc. Surg. 36 (1988), 151-156

GEBHARD, M.M., et al, Myocardial Protection and Ischemia Tolerance of the Globally Ischemic Heart, Thorac. Cardiovasc. Surg., 38 (1990), 55-59

GEBHARD, M., et al, Bretschneider’s Histidine Buffered Cardioplegic Solution: Concept; Application and Efficiency In Myocardial Protection in Cardiac Surgery, (ed.), A.J. Roberts, Marcel Dekker Inc., New York-Basel, 1987 pg. 95-119

GEBHARD, M., et al, Different Effects of Cardioplegic Solution HTK During Single or Intermittent Administration, Thorac. Cardiovasc. Surg., 32 (1984), 271-276

GEBHARD, M., et al, Calcium Free Cardioplegia, Eur. Heart. J., 4(1983), 151-160

HACHIDA, M., et al, Improvement of Postoperative Management Due to a New Cardioplegia HTK Solution, ICU & CCU 17 (9), (1993), 895-899

HACHIDA, M., et al, Effect of HTK Solution for Myocardial Preservation, J. Cardiovasc. Surg., 37 (1996), 269-274

HACHIDA, M., et al, Clinical Assessment of Prolonged Myocardial Preservation for Patients with a Severely Dilated Heart, Ann. Thoracic Surgery, 64 (1997), 59-63

HEINEMEYER, D., et al, Intracellular pH Measurement During Cardiac Arrest in Ventricular Myocardium by Bretschneider’s Cardioplegic Solution HTK and St. Thomas-Hospital Solution With and Without Procaine, Thorac. Cardiovasc. Surg. 35 (1987), 48-52

HOLPER, K., et al, Technical Refinements in Myocardial Protection: Infants – Adults, Thoracic Cardiovascular Surgery, 46 (1998), 292-297

KROHN, E., et al, The Cardioplegic Solution HTK: Effects on Membrane Potential, Intracellular K+ and Na+ Activities in Sheep Cardiac Purkinje Fibres, Plufgers Arch. 415 (1989), 269-275

LANTE, F.A., et al, Does the Use of Different Cardioplegia Influence Perioperative Proinflammatory Cytokine Production?, Thoracic Cardiovascular Surgeon, 2004; 52, Supp. 1.

MEISNER, H., et al, The Switch Operation: Indication and Results, in: Cardiothoracic Surgery, K. Minami et al (ed), Elsevier Science Pub., 1992, p. 17-33

PARKER, J.A.T.C., et al, Difference in Cardioprotective Potential of Buckbergs vs. Bretschneider Cardioplegia in Neonatal Pig Left Ventricle Cardiac Muscle Tissue by Evaluation of the Ex-Vivo Isovolumetric Contraction Pattern, Thoracic Cardiovascular Surgeon, 2004; 52, Supp. 1.

PRUESSE, C.J., Myocardial Protection in Patients with Poor Left Ventricular Function, Jordanian Cardiac Society Annual Meeting, Book of Abstracts, 2004; pg. 27-28

PRUESSE, C.J., et al, High Volume Cardioplegia, Annales Chirugiae et Gyaecologiae 76 (1987), 39-45

PRUESSE, C.J., et al, Myocardial Equilibration Procedures with High Volume Cardioplegia, Thai. J. Surg., 6, (1986), No. 4

PRUESSE, C.J., et al, Energy Demand of Cardioplegically Perfused Human Hearts, J. Of Cardiovascular Surgery, 26 (1985), 558-563

PRUESSE, C.J., et al, Postischemic Metabolism of Infant Hearts Following Either Ischemic or Cardioplegic Arrest, Perspectives in Pediatric Cardiology, Vol. 2, ed. G. Crupi et al

PRUESSE, C.J., et al, Cardioplegia for Repeat Valve Surgery, from: A Textbook of Cardioplegia for Difficult Clinical Problems (Engel RM et al (eds)), Futura Publishing Co., (1992), 203-219

PRUESSE, C.J., et al, Cardioplegia with an Intracellular Formulation, in: Ischemia-Reperfusion in Cardiac Surgery, PiperHM and Pruesse CJ (eds), Kiuwer Acad. Publishers, (1993), p. 107-134

SAKATA, J., et al, Comparison of Clinical Outcome between Histidine-Tryptophan-Ketoglutarate Solution and Cold Blood Cardioplegic Solution in Mitral Valve Replacement, Journal of Cardiac Surgery 13 (1998), 43-47

SCHAEFFER, U., et al, Damage to Endothelial Cells Induced by Several Solutions Used in Bypass Surgery, Thoracic Cardiovascular Surgeon (45), 1997: 168-171

SCHMIEDL, A., et al, Influence of Pretreatment on Interstitial and Intracellular Space of Canine Left-Ventricular Myocardium, Ada Anat., 138 (1990), 175-181

SCHMIEDL, A., et al, The Surface to Volume Ratio of Mitochondria, a Suitable Parameter for Evaluating Mitochondrial Swelling, Virchows Arch. A. Pathol. Anat.,416 (1990), 317-328

SCHNABEL, Ph.A., et al, Occurrence and Prevention of Contraction bands in Purkinje Fibres, Transitional Cells and Working Myocardium During Global Ischemia, Virchows Arch. A. Pathol. Anat., 417 (1990), 463-471

SCHNABEL, Ph.A., et al, Ultrastructural Effects Induced by Global Ischemia on the AV Mode Compared with the Working Myocardium, Virchows Arch. A. Pathol. Anat., 416 (1990) 317-328

SCHNABEL, Ph.A., et al, Myocardial Protection: Left Ventricular Ultrastructure and Different Forms of Cardiac Arrest, Thorac. Cardiovasc. Surg., 35 (1987), 148-156

STAPENHORST, K., Prolonged Safe Ischemic Cardiac Arrest Using Hypothermic Bretschneider Cardioplegia Combined with Topical Cardiac Cooling, Thorac. Cardiovasc. Surg., 29 (1981), 272-274

WILSON, G.J., et al, European versus North American Cardioplegia, Thorac. And Cardiovasc. Surgeon 38 (1990), 10-14